Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Monday, November 23, 2020

De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma

Cancer shared this article with you from Inoreader
Conditions:   HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage;   Oropharynx Cancer Interventions:   Procedure: Transoral robotic surgery;   Drug: Cisplatin - Dose Level 1;   Drug: Cisplatin - Dose Level 2;   Radiation: Dose Level 1;   Radiation: Dose Level 2 Sponsor:   Nebraska Methodist Health System Recruiting (Source: ClinicalTrials.gov)
View on the web

No comments:

Post a Comment